The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer - Wikidata - wikimedia - TriplyDB

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

http://www.wikidata.org/entity/Q34657144

about

Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling.

P2860

Q47131461-30A88F0D-9351-4038-98FD-90C3CBC0D34F

P2860

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

http://www.wikidata.org/entity/Q34657144

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

@ast

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

@en

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

@nl

type

label

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

@ast

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

@en

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

@nl

prefLabel

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

@ast

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

@en

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

@nl

P1433

Q34657144-DED3BE26-3EAC-44DC-A1A2-6408225597F6

P1476

Q34657144-DC1F4990-05E7-4C18-B373-15861AA28FFC

P2093

Q34657144-39E0286F-280F-447E-9B86-83CA6D749E0B

Q34657144-536BE020-D924-4306-B67C-20FE91E3FC3B

Q34657144-5509FEB8-43D0-4AD7-98ED-937670A0F16A

Q34657144-5BAFB06C-CE85-4AEC-B71C-64D64A5EE455

Q34657144-9D98E482-9477-4670-899F-C70776DB3362

Q34657144-9DA0C79E-D117-4131-BE2C-A193ABB8BEEE

Q34657144-AE2AD30F-E2AF-49F2-88C2-FD67FC4373AD

Q34657144-B3EB3248-6A24-4A91-8C45-209A58DFAA0A

Q34657144-C1D1E91A-A57C-44DB-975F-50E6C9C5BB83

Q34657144-FBC9DC18-FBE3-4D60-A5C7-722D60C73311

P2860

Q34657144-0613796C-6753-46DB-921B-5FC64A39C276

Q34657144-0BF3CFCE-1BD5-487B-ACE2-1DD0151CD078

Q34657144-24DE60A0-641B-406C-9C98-9007CD1B78BC

Q34657144-3648285F-71EF-4A97-A6FF-43F83F289EED

Q34657144-3B38D429-5925-4B3B-BEEE-2A0AAFD2B92B

Q34657144-4E76DDE4-1194-499D-BAF3-085A32823361

Q34657144-5208C329-939A-4C79-84E3-78545CDCDCF3

Q34657144-86EAF5F0-BFA4-48D9-A010-A52F0021E294

Q34657144-9968A965-C714-4931-A140-4B37529064E7

Q34657144-9D6491D8-B165-4F12-8D29-CA205E386168

P304

Q34657144-1862C2A3-2F08-4000-B47E-60C3BC126AAA

P31

Q34657144-EC33ACA9-BF28-45C9-AA9E-51556E927F1C

P356

Q34657144-18858ED1-C4C3-4111-BDD1-2C600FA6BCEB

P407

Q34657144-5F58E25B-0160-43DE-9AD6-7BEF27FF5E5C

P478

Q34657144-08C83D34-EE31-40C8-848B-1AEF3FF2BFA6

P577

Q34657144-D68CF283-21AA-4735-82F9-D61EA9D83659

P5875

Q34657144-3322EEC6-085C-46DD-8062-ADC25F804909

P698

Q34657144-8509B3A9-9C3C-4FDA-A1DE-FA187D72863A

P921

Q34657144-EDB6DF99-FDC9-4924-9D57-C352D7B33C84

P932

Q34657144-A336B1ED-873B-44A1-B3E5-D81AE4894392

P356

P1433

Clinical Medicine: Oncology

P1476

The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer

@en

P2093

Ahmad Zarzour

http://www.w3.org/2001/XMLSchema#string

Ahmed Mostafa

http://www.w3.org/2001/XMLSchema#string

Hai Bui

http://www.w3.org/2001/XMLSchema#string

Mahmoud Shehata

http://www.w3.org/2001/XMLSchema#string

Marshall Anderson

http://www.w3.org/2001/XMLSchema#string

Mb Rao

http://www.w3.org/2001/XMLSchema#string

Nagla A Karim

http://www.w3.org/2001/XMLSchema#string

Ninad Patil

http://www.w3.org/2001/XMLSchema#string

Peterson Pathrose

http://www.w3.org/2001/XMLSchema#string

Sandra Starnes

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2001

ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.

Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Prognostic role of ERCC1 in advanced non-small-cell lung cancer: a systematic review and meta-analysis.

Adjuvant therapy in non-small cell lung cancer: current and future directions.

Pharmacogenomics and gemcitabine.

P304

139-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CMO.S18369

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269770577

http://www.w3.org/2001/XMLSchema#string

P698

25520568

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

4259862

http://www.w3.org/2001/XMLSchema#string